Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to investigate the efficacy of bevacizumab, etoposide and
cisplatin in treating breast cancer patients with central nervous system metastasis
(including brain parenchymal and leptomeningeal metastasis).
Phase:
Phase 2
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborators:
Chang Gung Memorial Hospital Taichung Veterans General Hospital Taipei Veterans General Hospital, Taiwan